An estimated 5,000 people in the United States are living with Eosinophilic Granulomatosis with Polyangiitis (EGPA), a rare ...

Gastrointestinal involvement is common among patients with EGPA, with eosinophilic tissue infiltration, weight loss, and myalgia identified as significant predictors.

2,3 Depemokimab is currently being evaluated in phase III trials for the treatment of other IL-5 mediated diseases, including OCEAN for eosinophilic granulomatosis with polyangiitis (EGPA) 21 and ...

A STUDY has developed a predictive model for gastrointestinal (GI) lesions in patients with eosinophilic granulomatosis with polyangiitis (EGPA), shedding light on this serious complication and its ...

Introduction: This study aimed to identify new clinical phenotypes of microscopic polyangiitis (MPA) using a principal components analysis (PCA)-based cluster analysis. Methods: A total of 189 ...

She explains the lesions ... with edema and eosinophilic infiltrates in the dermis. The condition may be due to arthropod bites, leukemia, myeloproliferative disorders, cutaneous parasitic ...

As the first interleukin (IL)-5-targeting monoclonal antibody in late-stage trials, Fasenra targets eosinophilic inflammation, potentially reshaping treatment standards and reinforcing AstraZeneca’s ...

Nodular cutaneous amyloidosis may present either as an asymptomatic, localized cutaneous lesion or more widespread as a manifestation ... 3 Amyloid appears as an amorphous eosinophilic material by ...

Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is an extremely rare type of ... However, she did not report any vasculitis or skin rash or gastrointestinal symptoms. Her regular ...

Others, such as eosinophilic granulomatosis with polyangiitis, tend to develop in adults. Symptoms of autoimmune vasculitis can vary depending on the type of condition and which parts of your body ...